These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20830538)

  • 1. HIV and bone loss.
    Arora S; Agrawal M; Sun L; Duffoo F; Zaidi M; Iqbal J
    Curr Osteoporos Rep; 2010 Dec; 8(4):219-26. PubMed ID: 20830538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.
    Rothman MS; Bessesen MT
    Curr Osteoporos Rep; 2012 Dec; 10(4):270-7. PubMed ID: 23100110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
    Biver E; Calmy A; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Ferrari S; Frey D; Kressig RW; Lamy O; Lippuner K; Suhm N; Meier C
    Osteoporos Int; 2019 May; 30(5):1125-1135. PubMed ID: 30603840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.
    Ofotokun I; Weitzmann MN
    Curr Opin Endocrinol Diabetes Obes; 2010 Dec; 17(6):523-9. PubMed ID: 20844427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].
    Neumann E
    Z Rheumatol; 2006 Sep; 65(5):400, 402-6. PubMed ID: 16924451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between osteopenia/osteoporosis and the serum RANKL in HIV-infected patients.
    Konishi M; Takahashi K; Yoshimoto E; Uno K; Kasahara K; Mikasa K
    AIDS; 2005 Jul; 19(11):1240-1. PubMed ID: 15990584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of alveolar bone remodeling].
    Kobayashi Y; Udagawa N
    Clin Calcium; 2007 Feb; 17(2):209-16. PubMed ID: 17272878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of antiretroviral therapy: focus on bone density.
    Viganò A; Mora S
    Expert Opin Drug Saf; 2004 May; 3(3):199-208. PubMed ID: 15155148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.
    Katsarou O; Terpos E; Chatzismalis P; Provelengios S; Adraktas T; Hadjidakis D; Kouramba A; Karafoulidou A
    Ann Hematol; 2010 Jan; 89(1):67-74. PubMed ID: 19488753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of HIV to bone mineral density].
    Wessman M; Weis N; Katzenstein TL; Lebech AM; Thorsteinsson K; Hansen AE; Jensen JB
    Ugeskr Laeger; 2017 Sep; 179(36):. PubMed ID: 28874254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone disease in HIV infection.
    Saccomanno MF; Ammassari A
    Clin Cases Miner Bone Metab; 2011 Jan; 8(1):33-6. PubMed ID: 22461801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related metabolic comorbidities in the current ART era.
    Warriner AH; Burkholder GA; Overton ET
    Infect Dis Clin North Am; 2014 Sep; 28(3):457-76. PubMed ID: 25151566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of bone resorption by RANKL-RANK system].
    Harada S; Takahashi N
    Clin Calcium; 2011 Aug; 21(8):1121-30. PubMed ID: 21814016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection, bone metabolism, and fractures.
    Güerri-Fernández R; Villar-García J; Díez-Pérez A; Prieto-Alhambra D
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):478-83. PubMed ID: 25166038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antiretroviral therapy on bone metabolism markers in HIV-seropositive patients.
    Marques de Menezes EG; de Paula FJ; Machado AA; de Assis Pereira F; Barbosa Júnior F; Navarro AM
    Bone; 2013 Nov; 57(1):62-7. PubMed ID: 23891908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss in patients with HIV infection.
    Paccou J; Viget N; Legrout-Gérot I; Yazdanpanah Y; Cortet B
    Joint Bone Spine; 2009 Dec; 76(6):637-41. PubMed ID: 19945322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
    McGinty T; Mallon P
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of bone loss.
    Murray TM
    J Rheumatol Suppl; 1996 Aug; 45():6-10. PubMed ID: 8856644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management.
    Manfredi R
    AIDS; 2003 Oct; 17(15):2253-6. PubMed ID: 14523283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.